Mycobacterium kansasii
67 results
1 - 67Mycobacterium kansasii
- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- TREATMENT
- Pulmonary disease, HIV-negative, or HIV-positive without HAART
- Pulmonary disease, HIV-positive on HAART
- Disseminated disease
- Non-rifamycin-containing regimen
- Drug-Drug Interactions
- Selected Drug Comments
- OTHER INFORMATION
- Basis for recommendation
- References
- Media
Mycobacterium kansasii
- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- TREATMENT
- Pulmonary disease, HIV-negative, or HIV-positive without HAART
- Pulmonary disease, HIV-positive on HAART
- Disseminated disease
- Non-rifamycin-containing regimen
- Drug-Drug Interactions
- Selected Drug Comments
- OTHER INFORMATION
- Basis for recommendation
- References
- Media
Rifabutin
Rifabutin
Pyrazinamide
Pyrazinamide
Ethambutol
Ethambutol
Kanamycin
Osteomyelitis, Chronic
Isoniazid
Isoniazid
Streptomycin
Rifampin
Rifampin
Ethionamide
Amikacin
Pneumonia, bacterial
Clarithromycin
Clarithromycin
Gatifloxacin
Gatifloxacin
Ciprofloxacin
Ciprofloxacin
Mycobacterium spp.
Trimethoprim + Sulfamethoxazole
Trimethoprim + Sulfamethoxazole
Mycobacterium avium-complex (MAC, MAI, non-HIV)
Mycobacterium scrofulaceum
Mycobacterium xenopi
Mycobacterium gordonae
Mycobacterium abscessus
Mycobacterium fortuitum
Clofazimine
Clofazimine